Explore / Clinical trial
Clinical trial

Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP)

New York State Psychiatric InstituteCompletedPhase 2Started Dec 1, 201310 enrolledUnited StatesNCT02062658

Abstract

This study investigates if a single dose of IV Ketamine can rapidly improve Obsessive-Compulsive Disorder (OCD) symptoms and whether these effect can be maintained with a condensed course of a type of Cognitive Behavioral Therapy called Exposure and Response Prevention (EX/RP). You will be compensated for your time and travel. Participants must be between the ages of 18-55.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineOCD

Keywords

Obsessive-Compulsive Disorder

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.